We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




MEDICA LABMED FORUM 2024: International Experts Meet to Discuss Trending Topics in Laboratory Medicine

By LabMedica International staff writers
Posted on 26 Sep 2024

At MEDICA (Düsseldorf, Germany), the world’s premier trade fair for the healthcare industry and medical technology sector, this year’s event (November 11–14) will focus on the most exciting medical advancements. More...

Professional forums and their accompanying stage programs will delve into health IT, medical technology trends, healthcare policy, and laboratory medicine. Among the highlights is the MEDICA LABMED FORUM, known for its informative lectures and expert panel discussions, which has become a key feature of the MEDICA program. Around 6,000 companies have secured their spots at MEDICA 2024 and COMPAMED 2024, the concurrent supplier trade fair. Last year, both events together attracted a total of 83,000 visitors.

This year, the focus is on massive digitalization, networking, big data applications, and artificial intelligence (AI), collectively referred to as "Lab 4.0." On November 11, the opening day of MEDICA 2024, the MEDICA LABMED FORUM will address the hot topic of digitalization and AI. The morning session will concentrate on the shortage of skilled personnel, a pressing issue in laboratory medicine. Panelists will explore how automation and digitalization could help resolve this crisis. The afternoon session will shift to AI and big data tools that are either currently available or in development. Discussions will cover image recognition through deep learning, now standard for automated leucogram analysis, and the developmental state of machine learning for handling the vast multivariate data sets in laboratory diagnostics. A key question will be whether large language models can clarify complex lab findings and whether AI is making us smarter or dumber.

On the second day, discussions will focus on developments in laboratory medicine regarding cardiovascular diseases and cancer, the leading causes of mortality in the Western world. The cardiology section will highlight congenital heart defects, which are increasingly surgically correctable in childhood and are becoming more prominent in adult medicine due to extended life expectancy. Speakers will provide a clinical perspective and demonstrate the potential of machine learning in modern data evaluation. The afternoon session will cover highly sensitive cancer diagnostics using blood, known as “liquid biopsy,” which is revolutionizing oncology by allowing closer monitoring of tumor progression than conventional tissue biopsies. The session will also explore new techniques like analyzing methylation profiles for early detection of hereditary cancer forms and single-cell analysis using microfluidics.

On Young Scientists' Day, the next generation of researchers will present their perspectives on the future of laboratory medicine, offering insights into the latest advancements and challenges. Topics will include wearables for continuous diagnostic monitoring and the ongoing shortage of skilled personnel. The afternoon will feature discussions on personalized therapy based on individual laboratory parameters, the integration of laboratory and imaging diagnostics, and the role of AI in these fields.

The forum’s final day traditionally focuses on diagnostic research institutes and companies looking to introduce new applications in laboratory medicine. The theme for 2024 will center on aging, with sessions examining pathophysiology, diagnostics, and treatment. Topics will include the genetic and epigenetic factors influencing biological aging, protein misfolding as a basis for neurodegenerative diseases like Alzheimer's and Parkinson's, and the role of gut microbiota in strokes. As the forum’s "grand finale," discussions will address theories and practical approaches to slowing the aging process, such as anti-aging drugs, the effects of anti-inflammatory agents, environmental influences on aging in the central nervous system, and methods for repairing nervous system lesions.

Related Links:
MEDICA


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Drug Testing Assays
Atellica DT 250 Analyzer
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Dr. Maria “Ken” Figueroa is investigating how epigenetics can inform treatment paths for cancer patients. (Image Credit: Sylvester Comprehensive Cancer Center)

DNA Methylation May Help Predict Treatment Response in Myelodysplastic Syndromes

Myelodysplastic syndromes (MDS) are disorders in which the bone marrow does not produce healthy blood cells normally. Treatment selection can be challenging because clinicians cannot reliably predict which... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: Melioidosis is a serious, sometimes fatal infection caused by Burkholderia pseudomallei, a bacterium found in tropical and subtropical soil and surface water. (Image Credit: Adobe Stock)

Antibody Testing Informs Melioidosis Diagnosis and Surveillance in Emerging Regions

Melioidosis is a serious and sometimes fatal infection caused by the soil- and water-dwelling bacterium Burkholderia pseudomallei. People and animals can contract the disease through exposure to contaminated... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.